Citron Research alleged that Valeant Pharmaceuticals International Inc. (NYSE: VRX) falsified sales through a network of phantom pharmacies. The stock price plummeted $43.44 to $103.30.
Citron Research targets Valeant Pharmaceuticals
October 21, 2015 at 12:55 PM EDT
